US EditionShoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why - Shoulder Innovations (NYSE:SI)
Third-quarter revenue rose 58% to $11.8 million, with sales of implant systems up 53%, prompting a raised 2025 revenue forecast to $45-$46 million, projecting 42%-45% growth.
- On Tuesday, Shoulder Innovations Inc. shares climbed 21.04% to $13.75 in after-hours trading after the company released third-quarter results and raised its full-year revenue outlook.
- The company reported $11.8 million in third-quarter revenue, a 58% increase, and sold 1,584 implant systems with a gross margin of 76.2%.
- Despite revenue gains, costs rose as selling, general, and administrative expenses increased 78% to $15.1 million, and operating loss widened to $46 million, with net loss at $8.7 million.
- Management will host a conference call on November 11, 2025 at 4:30 p.m. ET, and the company held $137 million in cash, cash equivalents and marketable securities as of Sept. 30.
- CEO Rob Ball said the company sees substantial opportunities within a $2.8 billion addressable global market, while the press release cautioned that forward-looking statements and risk factors are not guarantees and emphasized Adjusted EBITDA as supplemental.
18 Articles
18 Articles
Shoulder Innovations (SI) Stock Rose 21% After-Hours: Here's Why - Shoulder Innovations (NYSE:SI)
Shoulder Innovations Inc. (NYSE:SI) shares climbed 21.04% in after-hours trading Tuesday, closing at $13.75, after the medical technology company reported third-quarter earnings that beat expectations and raised its full-year revenue outlook. Check out the current price of SI stock here. According to Benzinga Pro data, SI closed regular trading at $11.36, up $0.35, or 3.18%, on Tuesday. Q3 Revenue Growth Accelerates The Michigan-based company r…
Journal Gazette & Times-Courier
Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance
GRAND RAPIDS, Mich., Nov. 11, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the third quarter…
Shoulder Innovations (NYSE:SI) Given Overweight Rating at Piper Sandler
Shoulder Innovations (NYSE:SI – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Piper Sandler in a note issued to investors on Wednesday,Benzinga reports. They currently have a $18.00 target price on the stock. Piper Sandler’s price target indicates a potential upside of 19.36% from the stock’s previous close. A number of other equities […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
